Table 2.

Primary and Secondary Study Outcomes

	Study group (n = 272)	Control group (n = 271)	p
No. of patients with SSI (%)	5 (1.8)	14 (5.2)	.04
No. of patients with SSI and wound dehiscence (%)	1 (0.4)	2 (0.7)	>.99
No. of patients with SSI who required systemic antibiotic treatment (%)	0	4 (1.5)	.13
No. of patients with SSI who required hospital readmission (%)	0	3 (1.1)	.24
No. of patients with SSI who required surgical intervention (%)	0	0	-

	Study group (n = 5)	Control group (n = 14)
Time of SSI occurrence (d)	7.4 ± 1.14 (6-9)	9.1 ± 3.6 (3–14)	.26
No. of ambulatory visits	4.6 ± 1.67 (2-6)	2.9 ± 1.1 (1–4)	.02
Length of additional hospitalization (d)	0	8.2 ± 3.2 (5–11)	.22

Data are expressed as mean ± SD/ (range) or as frequency (%)

SSI = surgical site infection.